MDxHealth SA (MDXH)
2.74
+0.01
(+0.37%)
USD |
NASDAQ |
May 31, 16:00
2.76
+0.02
(+0.73%)
After-Hours: 20:00
MDxHealth Total Assets (Quarterly): 121.74M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 121.74M |
| December 31, 2023 | 129.13M |
| September 30, 2023 | 135.73M |
| June 30, 2023 | 142.54M |
| March 31, 2023 | 150.79M |
| December 31, 2022 | 119.14M |
| September 30, 2022 | 122.57M |
| June 30, 2022 | 58.51M |
| December 31, 2021 | 75.07M |
| June 30, 2021 | 46.38M |
| June 30, 2021 | 46.38M |
| December 31, 2020 | 31.86M |
| June 30, 2020 | 39.86M |
| June 30, 2020 | 39.86M |
| December 31, 2019 | 40.63M |
| June 30, 2019 | 49.88M |
| June 30, 2019 | 49.88M |
| December 31, 2018 | 65.48M |
| June 30, 2018 | 83.20M |
| June 30, 2018 | 83.20M |
| December 31, 2017 | 58.52M |
| June 30, 2017 | 66.66M |
| Date | Value |
|---|---|
| June 30, 2017 | 66.66M |
| December 31, 2016 | 67.72M |
| June 30, 2016 | 50.39M |
| June 30, 2016 | 50.39M |
| December 31, 2015 | 57.74M |
| June 30, 2015 | 55.16M |
| June 30, 2015 | 55.16M |
| December 31, 2014 | 30.95M |
| June 30, 2014 | 21.38M |
| June 30, 2014 | 21.38M |
| December 31, 2013 | 29.38M |
| June 30, 2013 | 35.31M |
| June 30, 2013 | 35.31M |
| December 31, 2012 | 19.95M |
| June 30, 2012 | 13.33M |
| June 30, 2012 | 13.33M |
| December 31, 2011 | 19.01M |
| June 30, 2011 | 25.87M |
| December 31, 2010 | 19.18M |
| June 30, 2010 | 22.69M |
| December 31, 2009 | 35.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
31.86M
Minimum
Dec 2020
150.79M
Maximum
Mar 2023
82.35M
Average
58.51M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Galapagos NV | 4.710B |
| UCB SA | 17.18B |
| Mithra Pharmaceuticals SA | 407.25M |
| Nyxoah SA | 122.05M |
| Celyad Oncology SA | 13.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 122.72M |
| Shareholders Equity (Quarterly) | -0.973M |
| Debt to Equity Ratio | -37.43 |
| Current Ratio | 1.688 |
| Net Debt Paydown Yield | -0.25% |